ChemicalBook > CAS DataBase List > PD 135158

PD 135158

Product Name
PD 135158
CAS No.
130325-35-8
Chemical Name
PD 135158
Synonyms
PD 135158;4-[[(1R)-2-[[(2R)-3-(1H-Indol-3-yl)-2-methyl-1-oxo-2-[[[[(1S,2R,4S)-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl]oxy]carbonyl]amino]propyl]amino]-1-phenylethyl]amino]-4-oxobutanoicacid
CBNumber
CB41400397
Molecular Formula
C42H61N5O11
Formula Weight
811.97
MOL File
130325-35-8.mol
More
Less

PD 135158 Property

storage temp. 
Store at +4°C
solubility 
<61.68mg/ml in DMSO
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Tocris
Product number
2608
Product name
PD135158
Purity
≥98%(HPLC)
Packaging
10
Price
$224
Updated
2021/12/16
Tocris
Product number
2608
Product name
PD135158
Purity
≥98%(HPLC)
Packaging
50
Price
$900
Updated
2021/12/16
Usbiological
Product number
256181
Product name
PD 135158
Packaging
10mg
Price
$559
Updated
2021/12/16
ApexBio Technology
Product number
B7127
Product name
PD135158
Packaging
50mg
Price
$1793
Updated
2021/12/16
American Custom Chemicals Corporation
Product number
API0019234
Product name
4-[[(1R)-2-[[(2R)-3-(1H-INDOL-3-YL)-2-METHYL-1-OXO-2-[[[[(1S,2R,4S)-1,7,7-TRIMETHYLBICYCLO[2.2.1]HEPT-2-YL]OXY]CARBONYL]AMINO]PROPYL]AMINO]-1-PHENYLETHYL]AMINO]-4-OXOBUTANOIC ACID
Purity
95.00%
Packaging
5MG
Price
$498.64
Updated
2021/12/16
More
Less

PD 135158 Chemical Properties,Usage,Production

Uses

PD 135158 (CAM 1028) is a selective CCKB receptor antagonist with an IC50 of 2.8 nM against mouse cortex CCKB. PD 135158 shows anxiolytic activity[1].

Biological Activity

Potent and selective, nonpeptide CCK 2 receptor antagonist (IC 50 values are 2.8 and 1232 nM for CCK 2 and CCK 1 respectively) that displays negligible affinity at GABA A , benzodiazepine, substance P, neurotensin, opioid, bradykinin and 5-HT 3 receptors (IC 50 > 10 μ M). Exhibits anxiolytic activity in elevated plus maze and social interaction tests and increases food intake in rats.

in vivo

PD 135158 (CAM 1028; 0.001-0.1 mg/kg; s.c.; once) enhances latent inhibition in the rat and shows antipsychotic potential[2].

Animal Model:Male Sprague-Dawley rats, conditioned suppression of drinking procedure model[2]
Dosage:0.001, 0. 01, and 0.1 mg/kg
Administration:0.2 mL/kg SC 30 min before prexposure and conditioning
Result:Elicited a clear latent inhibition effect under conditions that did not lead to latent inhibition in control rats.

IC 50

CCKBR: 2.8 nM (IC50); CCKAR: 1232 nM (IC50)

References

[1] Hughes J, et al. Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. Proc Natl Acad Sci U S A. 1990 Sep;87(17):6728-32. DOI:10.1073/pnas.87.17.6728
[2] Gracey DJ, et al. PD-135,158, a cholecystokinin(B) antagonist, enhances latent inhibition in the rat. Pharmacol Biochem Behav. 2000 Mar;65(3):459-63. DOI:10.1016/s0091-3057(99)00227-0

PD 135158 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

PD 135158 Suppliers

3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Fax
86-21-50328109
Email
3bsc@sina.com
Country
China
ProdList
15838
Advantage
69
EMMX Biotechnology LLC
Tel
888-539-0666
Fax
888-539-0666
Email
info@emmx.com
Country
United States
ProdList
8447
Advantage
60
TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
32435
Advantage
58
TargetMol Chemicals Inc.
Tel
4008200310
Email
marketing@tsbiochem.com
Country
China
ProdList
24961
Advantage
58
RD International Technology Co., Limited
Tel
18024082417
Email
market@ubiochem.com
Country
China
ProdList
9835
Advantage
58
Santa Cruz Biotechnology Inc
Tel
021-60936350
Email
scbt@scbt.com
Country
China
ProdList
6594
Advantage
58
ApexBio Technology
Tel
--
Fax
--
Email
sales@apexbt.com
Country
United States
ProdList
6251
Advantage
58
Guangzhou Tuoshan Biotechnology Co., Ltd.
Tel
19928332050
Country
CHINA
ProdList
161
Advantage
58

130325-35-8, PD 135158Related Search:


  • PD 135158
  • 4-[[(1R)-2-[[(2R)-3-(1H-Indol-3-yl)-2-methyl-1-oxo-2-[[[[(1S,2R,4S)-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl]oxy]carbonyl]amino]propyl]amino]-1-phenylethyl]amino]-4-oxobutanoicacid
  • 130325-35-8